PDCD1 and hepatocellular carcinoma: In addition, a recent study from Kim et al. pointed out that hyperprogressive disease (HPD), which occurs in a subset of patients with HCC treated with PD-1 inhibitors, was associated with worse OS and PFS, and it could be predicted by an elevated (>4.125) NLR [72].